Charcot-Marie-Tooth Awareness Month


WHEREAS, Charcot-Marie-Tooth (CMT) is one of the most common inherited peripheral neuropathy disorders, affecting approximately one in every 2,500 people; and

WHEREAS, CMT is characterized by a slow and progressive degeneration of the muscles in the foot, lower leg, and forearm, with extending weakness in the hands and loss of muscle tone; and

WHEREAS, it is important that doctors, medical professionals, and educators are aware of CMT symptoms and the obstacles faced by those affected; and

WHEREAS, in 2013, the Charcot-Marie-Tooth Association’s Strategy to Accelerate Research Initiative brought significant advances in research and development of therapies for CMT; and

WHEREAS, a partnership between the National Institutes of Health and university laboratories specializing in peripheral nerve biology has identified candidate drugs for the treatment of the most common type of CMT; and

WHEREAS, the CMT Association provides grassroots support for those affected by CMT and encourages members of the community to make a commitment to spreading awareness;

NOW, THEREFORE, I, Terence R. McAuliffe, do hereby recognize September 2014 as CHARCOT-MARIE-TOOTH AWARENESS MONTH in our COMMONWEALTH OF VIRGINIA, and I call this observance to the attention of all our citizens.